Morgan Stanley on Merck (MRK): Terns acquisition 'encouraging and consistent with prior commentary'
Go back to Morgan Stanley on Merck (MRK): Terns acquisition 'encouraging and consistent with prior commentary'| Merck & Co. (NYSE: MRK) | Delayed: 113.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.87 | 52 Week High | $65.46 | |||
| Open | $113.87 | 52 Week Low | $47.97 | |||
| Day High | $113.87 | P/E | 77.46 | |||
| Day Low | $113.87 | EPS | $1.47 | |||
| Volume | 3,839 | |||||

